Overview
- 137 inspections across 115 sites are on record.
- 132 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-01-31.
At a glance
Inspections
137
Sites
115
Observations
132
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Symbiosis Pharmaceutical Services Limited | 31 Jan 2025 | Biologics | |
| ROSLIN CELL THERAPIES LIMITED | 21 Jan 2025 | Biologics | View 483 → |
| BioReliance Corporation | 22 Nov 2024 | Biologics | View 483 → |
| Charles River Laboratories France CRLF | 28 Aug 2024 | Biologics | |
| SmartPractice Denmark ApS | 16 Aug 2024 | Biologics |
Sites inspected
Symbiosis Pharmaceutical Services LimitedStirling, United Kingdom1 insp.
ROSLIN CELL THERAPIES LIMITEDEdinburgh, United Kingdom1 insp.
BioReliance CorporationRockville, United States1 insp.
Charles River Laboratories France CRLFRomans, France1 insp.
SmartPractice Denmark ApSHillerod, Denmark1 insp.
Co-investigators
Investigators who share inspections with this person.
Simone E Pitts14 shared
Debra M Emerson13 shared
Jacqueline M Diaz Albert10 shared
Mihaly S Ligmond9 shared
Cynthia Jim7 shared
Burnell M Henry5 shared
Omotunde O Osunsanmi5 shared
Gwyn G Dickinson5 shared
Laurel A Beer4 shared
Hector A Carrero4 shared
Full investigator report
Get the verbatim findings behind Susan M Jackson's 132 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site